Cidara Therapeutics, Inc.
CDTXDelisted Jan 7, 2026- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001610618
Cidara Therapeutics, Inc. was delisted on Jan 7, 2026; its insiders filed their last Form 4 on Jan 9, 2026; 255 institutions reported holding it in 13F filings for Q4 2025, worth $7.36B in total; 3 superinvestors held it, including Maverick Capital and Soros Fund Management.
Q2 2023 vs. Q1 2023
How the institutions holding Cidara Therapeutics, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 54 | 52 | −2 |
| Shares | 27.1M | 26.3M | −853.7K (−3.1%) |
| Value | $34.4M | $29.7M | −$4.75M (−13.8%) |
New holders (6)
Institutions that held Cidara Therapeutics, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Connor, Clark & Lunn Investment Management Ltd. | 320,767 | $362.5K | 0.00% |
| Millennium Management LLC | 119,190 | $134.7K | 0.00% |
| Bridgeway Capital Management, LLC | 60,060 | $67.9K | 0.00% |
| Legacy Wealth Asset Management, LLC | 30,000 | $33.9K | 0.01% |
| Invesco Ltd. | 25,016 | $28.3K | 0.00% |
| Mackenzie Financial Corp | 22,566 | $25.5K | 0.00% |
Sold out (8)
Institutions that held Cidara Therapeutics, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Acadian Asset Management LLC | 941,574 | $1.19M |
| Jane Street Group, LLC | 306,526 | $389.3K |
| Simplex Trading, LLC | 19,559 | $24.0K |
| HRT Financial LP | 14,827 | $18.0K |
| Visionary Wealth Advisors | 13,008 | $16.5K |
| Two Sigma Securities, LLC | 11,592 | $14.7K |
| Stonepine Capital Management, LLC | 1,000 | $1.27K |
| Bank of America Corp | 724 | $919 |